Apg Asset Management N.V. Charles River Laboratories International, Inc. Transaction History

Apg Asset Management N.V.

$36.1 Billion
Q4 2024

A detailed history of Apg Asset Management N.V. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Apg Asset Management N.V. holds 30,104 shares of CRL stock, worth $4.58 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

30,104

Previous 7,755 288.19%

Holding current value

$4.58 Million

Previous $1.53 Million 263.92%

% of portfolio

0.02%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$178.58 - $220.69 $3.99 Million - $4.93 Million	22,349 Added 288.19%	30,104 $5.56 Million
Q3 2024 Nov 14, 2024	SELL	$187.96 - $245.29 $10 Million - $13.1 Million	-53,262 Reduced 87.29%	7,755 $1.53 Million
Q2 2024 Aug 14, 2024	BUY	$206.39 - $268.73 $1.29 Million - $1.68 Million	6,258 Added 11.43%	61,017 $12.6 Million
Q1 2024 May 14, 2024	BUY	$203.52 - $273.43 $3.31 Million - $4.45 Million	16,277 Added 42.3%	54,759 $14.8 Million
Q4 2023 Feb 13, 2024	SELL	$164.52 - $238.84 $448,481 - $651,077	-2,726 Reduced 6.62%	38,482 $9.1 Million
Q3 2023 Nov 14, 2023	SELL	$194.44 - $217.61 $884,507 - $989,907	-4,549 Reduced 9.94%	41,208 $8.08 Million
Q2 2023 Aug 14, 2023	SELL	$183.71 - $210.25 $4,409 - $5,046	-24 Reduced 0.05%	45,757 $9.62 Million
Q1 2023 May 12, 2023	SELL	$191.89 - $259.92 $1.46 Million - $1.97 Million	-7,592 Reduced 14.22%	45,781 $9.24 Million
Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $8.53 Million - $10.8 Million	43,282 Added 428.92%	53,373 $11.6 Million
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $601,687 - $826,280	3,298 Added 48.55%	10,091 $2.03 Million
Q2 2022 Aug 12, 2022	BUY	$204.13 - $302.4 $876,330 - $1.3 Million	4,293 Added 171.72%	6,793 $1.39 Million
Q1 2022 May 12, 2022	SELL	$255.51 - $362.11 $25,551 - $36,211	-100 Reduced 3.85%	2,500 $638,000
Q4 2021 Feb 11, 2022	SELL	$351.38 - $448.68 $456,794 - $583,284	-1,300 Reduced 33.33%	2,600 $861,000
Q3 2021 Nov 15, 2021	SELL	$372.64 - $458.3 $708,016 - $870,770	-1,900 Reduced 32.76%	3,900 $1.39 Million
Q2 2021 Aug 13, 2021	BUY	$294.17 - $371.65 $1.71 Million - $2.16 Million	5,800 New	5,800 $1.81 Million
Q3 2018 Nov 09, 2018	SELL	$112.11 - $134.54 $14.4 Million - $17.3 Million	-128,800 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$102.37 - $117.25 $14.2 Million - $16.3 Million	-138,800 Reduced 51.87%	128,800 $12.4 Million
Q1 2018 May 14, 2018	SELL	$98.19 - $115.2 $9.94 Million - $11.7 Million	-101,200 Reduced 27.44%	267,600 $23.2 Million
Q4 2017 Jan 24, 2018	BUY	$100.43 - $118.09 $26.8 Million - $31.5 Million	266,700 Added 261.21%	368,800 $33.6 Million
Q3 2017 Oct 19, 2017	BUY	$96.72 - $109.26 $9.88 Million - $11.2 Million	102,100	102,100 $11 Million

Others Institutions Holding CRL

# of Institutions

703

Shares Held

52.8M

Call Options Held

157K

Put Options Held

413K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $7.73B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Apg Asset Management N.V. with notifications on news.

Account

Apg Asset Management N.V. Charles River Laboratories International, Inc. Transaction History